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INTRODUCTION
Severe Epstein-Barr virus (EBV) disease has been observed
increasingly in immune deficient hosts having congenital
immunodeficiency syndrome or acquired immune suppres-
sion. In an immune competent host, EBV may be eliminat-
ed by cytotoxic T cells evoked by the EBV antigen, or the
virus can survive in the human body through a latent infec-
tion by maintaining a balance with the host. Sometimes, a
fulminant EBV disease occurs in previously healthy hosts.
Fulminant EBV diseases have been reported under various
names including fatal EBV-associated hemophagocytic syn-
drome or severe chronic active EBV infection (1, 2). Severe
chronic active EBV infection commonly occurs in children
or adolescents, but rarely in adults, and is characterized by
chronic illness lasting more than 6 months and an elevated
titer of EBV-associated antibodies, pancytopenia, hemophago-
cytosis, disseminated intravascular coagulation, hepatosple-
nomegaly, and lymphadenopathy (3). Unlike classic infectious
mononucleosis, T-lymphocytes or NK cells instead of the B-
cell harbor the EBV genome, and some cases progress to T
or NK-lymphoproliferative disease (4). 
We report a case of chronic active EBV infection occur-
ring in a 61-yr-old Korean woman with a reappraisal of the
current diagnostic criteria. 
CASE REPORT
The patient was referred to the Hemato-oncology Depart-
ment because of a fever of unknown origin. She had been suf-
fering from chronic hepatitis C since 4 yr prior to her visit,
when elevated AST/ALT and positive HCV-RNA of periph-
eral blood were noted. IFN- and ribavirin had been inter-
mittently administered at an outside hospital. Two months
prior to the transfer to our hospital, she had a fever that was
not improved by discontinuation of IFN- and ribavirin.
On admission, her body temperature was 38.5℃, her blood
pressure 140/80 mmHg, and her respiration rate 20/min. She
appeared chronically ill. Blood findings were Hb 7.9 g/dL,
platelet 61,000/ L, and WBC 3,900/ L with differentials
of segmented neutrophils 48.4%, lymphocytes 34.6%, and
monocyte 14.9%. The reticulocyte count was 6.6% and ESR
33 mm/hr. A liver function test revealed total bilirubin of 1
mg/dL, AST 46  L, ALT 19  L, and  -GT 36  L. Total pro-
tein was 8.7 g/dL, globulin 6.3 g/dL, and albumin 2.4 g/dL.
An immunoelectrophoresis of the blood protein revealed poly-
clonal hypergammaglobulinemia. LDH was 1,030.4 IU/L,
total iron binding capacity 168  g/dL, iron 13  g/dL, and
ferritin 2,050 ng/mL. A blood coagulation test showed in-
creased prothrombin time, FDP, and D-dimer. The results
of the serologic test were anti-HBs Ab (+),  anti-HCV IgG
Ab (+), EBV VCA-IgG (+), EBV VCA-IgM (-), EBNA (+),
and EA (-). Both direct and indirect Coombs’ tests were posi-
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Severe Chronic Active EBV Infection in an Adult Patient
: Case Report
Severe chronic active Epstein-Barr virus (EBV) infection is a rare and life-threaten-
ing illness. Although the criteria for diagnosis include chronic or recurrent infectious
mononucleosis-like symptoms lasting more than 6 months and high titers of anti-EBV
antibodies, clinical and laboratory findings may be heterogeneous and flexible appli-
cation of those criteria is necessary in cases showing typical clinical and patholog-
ic findings. We report a case of severe chronic active EBV infection in a 62-yr-old
female patient who showed classical clinical findings with infiltration of EBV-infect-
ed T lymphocytes in the bone marrow, spleen, and lymph nodes, and died four
months after presentation.
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tive.
The peripheral blood smear showed normocytic and nor-
mochromic RBCs with poikilocytosis and anisochromia. Bone
marrow aspirate showed hypercellular marrow with the infil-
tration of many small and medium sized T-lymphocytes with-
out significant atypia, plasma cells, and many histiocytes.
PCR analysis for the TCR gene rearrangement followed
by SSCP showed a polyclonal pattern of the TCR gene. 
A CT scan of the abdomen revealed a huge spleen of 17
×14 cm in size and mild hepatomegaly. There were multi-
ple subcapsular, low attenuating lesions. Multiple enlarged
lymph nodes, measuring up to 3.7 cm in diameter, were
found in the porta hepatis, portocaval, retropancreatic, and
aortocaval regions. 
On the 6th day of admission, steroid was administered
under the impression of autoimmune hemolytic anemia, but
hematologic findings were not improved. Fever was persis-
tent. On the 23rd hospital day, splenectomy with a paraaor-
tic lymph node biopsy was done. The spleen was 18×16×
7 cm and weighed 685 g. The cut surface showed multifocal
infarcts involving about 30% of the parenchyma. Microscop-
ically, red pulp was markedly expanded with atrophic white
pulp. In the red pulp, there was diffuse infiltration of histio-
cytes showing erythrophagocytosis in the splenic cord and
sinusoids. A few histiocytes phagocytosed platelets. Besides
the histiocytes, many plasma cells had infiltrated the splenic
cord. In some areas, extramedullary hematopoiesis and infarct
of splenic tissue were observed. Paraaortic lymph node dis-
played loss of lymphoid follicles and paracortical expansion
by diffuse infiltration of polyclonal plasma cells. The sinus
contained a few erythrophagocytosing histiocytes. Immuno-
staining revealed many T-lymphocytic infiltrations with a
predominance of CD4-positive cells in the red pulp as well
as in the white pulp. Double procedure for CD3 immunohis-
tochemistry and EBV in situ hybridization revealed numer-
ous CD3-positive T lymphocytes harboring the EBV genome
in their nuclei. CD56 was negative in those lymphocytes. A
few B lymphocytes exhibited the EBV signal. The plasma
cells in the bone marrow, spleen, and lymph nodes demon-
Fig. 2. Infiltration of lymphoplasma cells and erythrophagocytic
histiocytes in spleen (H&E stain, ×400).
Fig. 3. Intranuclear positive signals in lymphoid cells (EBER in situ
hybridization ×400). 
Fig. 4. CD3-positive T lymphocytes were harboring EBV genome
in their nuclei (Double procedure for CD3 immunohistochemistry
and EBER in situ hybridization ×400).
Fig. 1. The spleen was markedly enlarged and weighed 685 g.
The cut surface showed multifocal necrosis and diffuse conges-
tion.Severe Chronic Active EBV Infection 455
strated a polyclonal light chain expression pattern.
After splenectomy, complete blood count was temporarily
elevated, but fell again. One week after the surgery, the patient
manifested body edema with ascites and petechiae of the skin.
She also showed hyperbilirubinemia and elevated AST/ALT. 
Under the diagnosis of chronic active EBV infection and
DIC, acyclovir was administered to the patient and chemo-
therapy was planned. On the 34th hospital day, after the inser-
tion of a Hickman catheter for chemotherapy, she complained
of dyspnea. Chest radiography revealed bilateral pleural effu-
sion and diffuse increase of hazziness of both lung fields. A
bronchoscopic examination and chest radiographic findings
indicated acute respiratory distress syndrome with diffuse
alveolar hemorrhage. The cytomegalovirus was isolated in
the culture of the bronchoalveolar larvage. The patient got
worse rapidly. On the 65th hospital day, she was discharged
with multiorgan failure by disseminated intravascular coag-
ulation and septic shock.
DISCUSSION
EBV infection can cause a broad spectrum of diseases de-
pending on the host’s immune status. Primary infection in
adolescent or early adult life can be manifested as a classic
infectious mononucleosis characterized by fever, hepatos-
plenomegaly, lymphadenopathy, and an increase of activated
CD8+ T lymphocytes in the peripheral blood. Fulminant
EBV infection has been described under the name of fatal
infectious mononucleosis and EBV-associated hemophagocyt-
ic syndrome in toddlers or young children. It is characterized
by fever, hepatosplenomegaly, lymphadenopathy, hemophago-
cytosis in various tissues, and a tendency to pancytopenia, often
leading to a fatal outcome (5, 6). Some cases of fatal infec-
tious mononucleosis are associated with X-linked lympho-
proliferative syndrome (7). Serologic profiles of those patients
showed anti-VCA IgM, and IgG-positive, and anti-EBNA1-
negative, which are diagnostic of a primary infection.
Some cases of fulminant EBV infection have been termed
severe chronic active EBV infection (SCAEBV). The first
patient described in 1978 was a 5-yr old girl with chronic in-
fectious mononucleosis-like symptoms that had persisted for
a long time. The patient also had extraordinarily elevated lev-
els of IgG antibody titers against VCA and EA with EBNA-
positive cells in circulation (8). Thereafter, some patients with
a similar type of disease were reported, especially in the Asia.
In Korea, only two cases have been described in the litera-
ture (9, 10). The clinical courses of these patients were fatal.
The life-threatening complications included hemophagocyt-
ic syndrome, interstitial pneumonia, lymphoma, coronary
artery aneurysm, or central nervous system involvement. In
1988, Straus et al. proposed the criteria of SCAEBV, which
included severe illness lasting more than 6 months, histologic
evidence of major organ involvement, abnormal EBV anti-
body titers, and increased quantities of EBV in affected tis-
sues (11). Using the Straus et al. criteria as a guideline, Okano
et al. reviewed the clinicopathologic and laboratory findings
of 26 patients previously reported in the English literature, as
well as their 10 cases, and emphasized that all of the patients
had extremely high antibody titers against the EBV (12).
However, the cases reported afterward did not always satisfy
the proposed criteria by Straus et al. Some patients showed
a duration of illness of less than 6 months, and other patients
lacked abnormal patterns of EBV-related antibodies. In 1995,
Ishihara et al. described the clinical and laboratory findings
of 39 children with SCAEBV infection registered in Japan.
In their series, past histories of hypersensitivity to mosquito
bites were identified in 31.3% of patients, and high anti-
EBV titers were noted in 28.2% of patients for anti-VCA
IgG and in 57.1% of patients for anti-EA IgG (13). Recent-
ly, Kimura et al. analyzed 30 patients with SCAEBV and
identified high EBV-related antibody titers in only one third
of the patients. They also noted high viral loads detected by
real-time quantitative PCR in the peripheral blood (more
Fig. 5. Infiltrated lymphoid cells are predominantly CD4-positive
cells (PAP stain, ×400).
Fig. 6. Minority of infiltrated lymphocytes express CD8 (PAP, ×
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than 102.5 copies/ g DNA) in all of the patients (14). Based
on these findings, Okano et al. suggested that virologic cri-
teria for diagnosis may be altered to either or both extremely
high antibody titers against EBV-replicative antigens and/or
increased genome copies in tissues (15). 
In the present patient, quantitative analysis of anti-EBV
antibody titer and viral load quantitated by real-time PCR
was not performed, but a pathologic examination identified
many EBV-infected T-lymphocytes that had infiltrated in
the spleen, lymph nodes, and bone marrow. Moreover, the
patient showed fever, lymphadenopathy, and hepatospleno-
megaly; and she pursued an aggressive fulminant clinical
course with hemophagocytic syndrome, which is a typical
clinical feature of severe chronic active EBV infection. 
The short clinical course of 4 months from the onset of
disease to death in the present patient does not satisfy the
criteria of disease duration as given by previous authors, who
emphasized an illness lasting more than 6 months’ duration
(12). However, a careful review of previous reports revealed
that a few patients showing typical clinical and laboratory
findings died of the disease at less than 2 months after the
onset of the disease (16). Therefore, the present case suggests
that the diagnosis of SCAEBV should be based on the con-
stellation of clinical and laboratory findings and should not
be limited by simple numerical criteria for disease duration
or by laboratory parameters. 
The majority of patients with SCAEBV at the onset of
symptoms have been children and adolescents. Their aver-
age age was 8.3 yr. In the series by Okano et al. and Kimura
et al., only 2 of 56 patients were over 30 yr-old at the onset
of the disease, and there were no patients who were more
than 60 yr-old (12, 14). In consideration of serologic pro-
files showing detectable IgG antibody titers to EBNA along
with high titers of IgG anti-VCA and anti-EA antibodies,
most young patients with CAEBV appeared to have had active
EBV infections and had already suffered from primary EBV
infection at the onset of CAEBV. Many cases of CAEBV in
older patients may occur with the reactivation or reinfection
of the EBV.
In the present case, a double procedure for immunohisto-
chemistry and EBER in situ hybridization revealed that nu-
merous CD3-positive T lymphocytes had harbored the EBV
genome in their nuclei. Unlike classical infectious mononu-
cleosis in which EBV infects B cells via the EBV receptor
on the cell surface, which are eliminated by EBV-antigen
directed cytotoxic T cells, SCAEBV is characterized by per-
sistent EBV infection into T or NK cells and the prolifera-
tion of these EBV-positive populations for long periods (17,
18). A recent study by Kimura et al. demonstrated the clin-
ical and virologic differences between the two subgroups of
SCAEBV infecting the T or NK cell. The T cell type CAEBV
tended to show high titers of anti-EBV-related antibodies
and a tendency of early mortality compared to the NK cell
type CAEBV (14). Infection of the T-cell, instead the B-cell,
by EBV is also observed in EBV-associated hemophagocytic
syndrome (EBV-HPS), which can be associated with acute
EBV infection. In a study by Kasahara et al., 4 patients with
acute EBV-HPS showed predominant CD8+ EBV infected
T cells; whereas dominant EBV-infected cells in patients with
CAEBV were CD8+T cells or CD4+T cells or NK. The dif-
ference of predominantly infected cells  between acute EBV-
HPS and CAEBV might be ascribed to the differences in the
time of analysis after the onset of disease; both the CD4+and
the CD8+ T cells became infected with the virus as the dis-
ease progressed (4). 
Infectious mononucleosis is common in western countries,
but the majority of the fulminant EBV infections including
EBV-HPS and SCAEBV infection has been reported in Asia,
including Japan and Taiwan. This suggests a certain racial
difference in the immunological function which controls EBV
infection. Although the patients reported hitherto had no
proven immune defects, it has been suggested that a defect
in the gene essential for regulating lymphocyte activation and
proliferation may exist. Another suggestion is that the virus
may escape from the immune surveillance by the host because
of the mutation of the viral genes. In the present patient,
chronic hepatitis C virus infection and INF- treatment might
have caused the immune dysfunction; however, the clinical
course does not support a causal relationship between HCV
infection and SCAEBV infection. 
In summary, SCAEBV infection is a fulminant disease
caused by EBV. Although high antibody titers for EBV anti-
gens and duration of illness are included in the diagnostic
criteria, flexible application of those criteria is necessary in
cases showing typical clinical and pathologic findings.
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